Agility Life Sciences Forge Strategic Partnership With SolitekVicky Coghlan2024-11-28T14:06:37+00:00April 3rd, 2023|Article, Headline Article, MediCity Nottingham, News|
Alveron Pharma Commences Clinical Trial Of New Intracranial Haemorrhage DrugVicky Coghlan2024-11-28T14:47:31+00:00March 31st, 2023|BioCity Nottingham, News|
Myconeos Innovate UK Smart Grant SuccessVicky Coghlan2023-03-28T14:48:14+01:00March 28th, 2023|BioCity Nottingham, News|
New Platform Set To Accelerate Early-Stage Targeted Protein Degradation ProgrammesVicky Coghlan2024-11-28T14:07:30+00:00March 7th, 2023|Article, BioCity Nottingham, News|
£20m Series A Funding For Two Pioneer Group Accelerator Programme GraduatesVicky Coghlan2023-03-09T15:14:09+00:00February 15th, 2023|Accelerator, Headline Article, News|
Pioneer Group Announce Lead Investment In Selentus ScienceVicky Coghlan2024-11-28T14:49:26+00:00February 7th, 2023|BioCity Nottingham, Investment, News|
